These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36229261)

  • 1. Management of tinea capitis in children following the withdrawal of griseofulvin from the French market: A fast-track algorithm proposed by the Center of Evidence of the French Society of Dermatology.
    Maruani A; Barbarot S; Gangneux JP; Caseris M; Moreau C; Brun S; Botterel F; Menotti J; Toubiana J; Chouchana L; Beylot-Barry M; Dupin N; Guillot B; Chosidow O
    Ann Dermatol Venereol; 2022 Dec; 149(4):238-240. PubMed ID: 36229261
    [No Abstract]   [Full Text] [Related]  

  • 2. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the management of tinea capitis in children.
    Kakourou T; Uksal U;
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G
    Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
    Bennett ML; Fleischer AB; Loveless JW; Feldman SR
    Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to cope with tinea capitis?].
    Lateur N
    Rev Med Brux; 2004 Jun; 25(3):148-52. PubMed ID: 15291446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of terbinafine in children.
    Gupta AK; Cooper EA; Lynde CW
    Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral terbinafine in tinea capitis in children.
    Gruseck E; Splanemann V; Bleck O; Ring J; Abeck D
    Mycoses; 1996; 39(5-6):237-40. PubMed ID: 8909037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory monitoring during antifungal treatment of paediatric tinea capitis.
    Aleohin N; Bar J; Bar-Ilan E; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2021 Feb; 64(2):157-161. PubMed ID: 33064847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
    Bar J; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of scalp ringworm.
    Drug Ther Bull; 1996 Jan; 34(1):5-6. PubMed ID: 8746192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.